The DEA's waiting period on its proposed 7-OH order ended November 13, 2026. As of November 19, the final order still has not appeared in the Federal Register. In the meantime, eight U.S. senators have asked federal regulators to tighten the threshold before it takes effect, a 60 Minutes segment has put the decision in the national spotlight, and two local governments have drawn their own lines between natural kratom and concentrated products.
Here is where things stand.
The Federal Order Is Still Pending
On October 14, 2026, the DEA published a notice of intent to temporarily place 7-hydroxymitragynine (7-OH) and mitragynine pseudoindoxyl (MGPI) in Schedule I above a threshold. A product would fall under the order if it contains more than 1 milligram of those compounds per gram (or per milliliter for liquids), or if it has a mitragynine-to-7-OH ratio below 100. We walked through how that two-part test works in HHS and DEA Just Drew a Line on 7-OH.
Under federal law, a temporary scheduling order can be published no sooner than 30 days after the notice. That date passed on November 13. A search of the Federal Register on November 19 shows the October notice as the most recent 7-OH document, so the order is not yet in effect.
The August 26 temporary order that placed MGPI, MGM-15, and MGM-16 in Schedule I remains in place.
Eight Senators Ask DEA and FDA to Reconsider
On November 16, Senate Judiciary Committee Chairman Chuck Grassley and seven colleagues sent a letter to DEA Administrator Terrance Cole and Acting FDA Commissioner Kyle Diamantas. The other signers are Senators Susan Collins, Rick Scott, Mike Crapo, Bill Cassidy, Jerry Moran, Shelley Moore Capito, and James Risch.
The letter asks for three things:
- From the FDA: the scientific and medical evaluations behind the 1 milligram per gram threshold, and a written justification for it.
- From the DEA: reconsideration of the higher threshold and a return to the earlier, stricter approach, or an explanation of why not.
- A deadline: responses by November 30, 2026.
The senators point out that the revised threshold doubles the earlier 0.5 milligram per gram figure, and they call the combined threshold "inappropriately high and unsound." The letter does not ask regulators to schedule natural kratom leaf or mitragynine. Pain News Network reported that it is unclear whether the letter could delay or change the order.
The 60 Minutes Segment and the AKA's Response
On November 15, CBS's 60 Minutes aired a segment on kratom and the federal threshold decision. Two days later, the American Kratom Association demanded corrections. The AKA says the broadcast described the threshold change as a twentyfold increase, when the limit moved from 0.5 to 1 milligram per gram. "That is a twofold increase," the AKA wrote, not a twentyfold one. It also says the segment left out the 100-to-1 ratio requirement.
The two sides disagree on the policy, but the arithmetic is checkable. The senators' letter and the AKA both describe the change as a doubling of the per-gram limit. For background on the industry group, see our explainer on the American Kratom Association.
Local Rules: Hillsborough County and Philadelphia
Two local governments acted this month, and both drew a line between concentrated products and other kratom.
- Hillsborough County, Florida. On November 10, county commissioners voted 7-0 to ban the sale and marketing of concentrated or chemically altered kratom products, including 7-OH, MGM-15, and MGM-16, in unincorporated areas, according to WUSF. Kratom in its natural, unaltered form is exempt. Violations are misdemeanors.
- Philadelphia. A city ordinance took effect November 12, according to FOX 29. It bars sales of kratom products with more than 2 percent 7-OH as a share of total alkaloids, products with synthetic versions of those compounds, and sales to anyone under 21. The ordinance also includes a broader provision on intoxicating substances, and the report notes that at least one local retailer reads it as reaching natural leaf. A retailer permit system will start once the city issues regulations.
Hillsborough's ordinance fits with Florida's state rules, which we cover in Is Kratom Legal in Florida? For how local bans differ from state and federal rules, see our guide to kratom ban laws.
What It Means for Natural Leaf
Nothing changed for natural leaf kratom at the federal level this week. The pending DEA order, the senators' letter, and the Hillsborough ordinance all focus on 7-OH and concentrated or synthetic compounds. Whether a specific product clears the federal test depends on its measured 7-OH content and its ratio to mitragynine, which is why the certificate of analysis matters. Our guide on how to read a kratom lab report shows where to find both numbers.
Where We Stand
We support strict rules for concentrated and synthetic products, mandatory testing, accurate labeling, enforced age limits, and enforcement against sellers who break the law. We do not carry 7-OH products, MGPI, MGM-15, or MGM-16. A measurable standard gives regulators and retailers a clear line, and we will follow whatever line is final.
We will update this post when the DEA publishes its order or responds to the senators. We comply with all applicable state and local laws. Orders to restricted areas are not fulfilled. Check your local regulations before ordering, and email orders@nuwavebotanicals.com with questions.
Sources
- Federal Register: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Threshold in Schedule I, notice of intent (October 14, 2026)
- Sen. Grassley et al.: Letter to DEA and FDA on the 7-OH threshold (November 16, 2026)
- Pain News Network: Eight U.S. senators want DEA to reconsider 7-OH scheduling (November 17, 2026)
- American Kratom Association: AKA demands CBS 60 Minutes correct major errors (November 17, 2026)
- WUSF: Hillsborough bans sales of concentrated and chemically altered kratom products (November 11, 2026)
- FOX 29: Philadelphia's kratom ban, hemp restrictions take effect Thursday (November 11, 2026)
FDA Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Kratom products are intended strictly for individuals 18 years of age or older, or 21+ where required by applicable state law.